You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 3, 2025

Details for Patent: 4,933,168


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,933,168
Title: Stable, crystalline flunisolide
Abstract:A unique crystalline polymorphic form of flunisolide is disclosed which is stable in aerosols such as Freon.RTM. mixtures and is valuable in the treatment of respiratory diseases, particularly bronchial asthma and allergic rhinitis.
Inventor(s): Jones; Richard E. (Palo Alto, CA), Haringer; Gisela T. (Watsonville, CA)
Assignee: Syntex Pharmaceuticals International Limited (Hamilton, BM)
Application Number:06/301,922
Patent Claim Types:
see list of patent claims
Compound; Use; Composition; Delivery;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 4,933,168: A Detailed Analysis

Introduction

Patents are a cornerstone of innovation, providing inventors and companies with exclusive rights to their inventions. The United States Patent 4,933,168, hereafter referred to as the '168 patent, is a specific example that can be analyzed to understand the intricacies of patent scope, claims, and the broader patent landscape.

What is the '168 Patent?

To begin, it is essential to identify the subject matter of the '168 patent. While the specific details of this patent are not provided in the sources, a general approach to analyzing any patent involves understanding its title, abstract, and claims.

Patent Title and Abstract

The title and abstract of a patent provide a brief overview of the invention. For example, if the '168 patent pertains to a technological innovation, the title might reflect the core concept, and the abstract would summarize the key aspects of the invention, including its purpose and main features.

Patent Claims

Types of Claims

Patent claims are the heart of any patent, defining the scope of protection granted to the inventor. There are two primary types of claims: independent claims and dependent claims.

  • Independent Claims: These claims stand alone and define the invention without reference to other claims. They are crucial as they set the broad boundaries of what is protected[5].
  • Dependent Claims: These claims refer back to and further limit the scope of an independent claim. They often add specific details or variations to the independent claims.

Claim Construction

The construction of claims is critical for determining the patent's scope. Claims must be clear, concise, and exact to meet the enablement requirement under 35 U.S.C. §112(a). This means the patent specification must describe the invention in such detail that a person skilled in the art can make and use the invention without undue experimentation[5].

Enablement Requirement

The enablement requirement is a key statutory provision that ensures the patent specification is sufficient to enable a person skilled in the art to make and use the invention. This requirement has been reinforced by numerous court decisions, including the Supreme Court's ruling in Amgen Inc. v. Sanofi, which emphasized that the specification must enable the entire class of processes or products claimed[5].

Patent Scope

Determining Scope

The scope of a patent is defined by its claims. The broader the claims, the wider the scope of protection. However, broad claims must still meet the enablement and other statutory requirements to be valid.

Patent Scope Measurements

The USPTO has developed various measures to assess patent scope, including those derived from the Patent Claims Research Dataset. This dataset provides detailed information on claims from U.S. patents and applications, allowing for the analysis of claim-level statistics and document-level statistics. Such measurements help in understanding the breadth and depth of patent protection[3].

Patent Landscape

Historical Context

Understanding the historical context in which the '168 patent was granted is crucial. Patents granted in the late 20th century may have different characteristics compared to modern patents due to changes in technology, legal interpretations, and patent office practices.

Related Patents and Prior Art

Analyzing the patent landscape involves identifying related patents and prior art. Tools like the USPTO's Global Dossier and Public Search Facility can be used to find related applications and patents, helping to determine how the '168 patent fits into the broader technological landscape[4].

Patent Quality and Examination

USPTO's Enhanced Patent Quality Initiative

The USPTO has been working to improve patent quality through various initiatives. This includes defining patent quality more consistently and reassessing the time allotted for examination. These efforts aim to ensure that patents, like the '168 patent, meet the statutory requirements and are of high quality[1].

Application Readiness

The quality of the patent application at the time of submission also plays a significant role. The USPTO's Application Readiness Review Form (ARRF) helps in assessing whether an applicant has provided sufficient information for an effective application. This process can impact the pendency and quality of the patent[1].

Legal and Regulatory Framework

Statutory Requirements

The '168 patent must comply with the statutory requirements outlined in the Patent Act, including novelty, non-obviousness, and the enablement requirement. These requirements ensure that the patent is valid and enforceable[5].

Court Decisions

Court decisions, such as those from the Supreme Court, provide guidance on interpreting these statutory requirements. For instance, the Amgen Inc. v. Sanofi case highlights the importance of the enablement requirement and how it impacts the validity of patent claims[5].

Impact on Industry and Innovation

Protection and Incentive

Patents like the '168 patent provide inventors and companies with exclusive rights, which can be a powerful incentive for innovation. However, the scope and claims of the patent must be carefully crafted to ensure they do not overly restrict future innovation.

Licensing and Litigation

The scope and claims of a patent can also influence licensing agreements and litigation. Broad, valid claims can strengthen a patent holder's position in negotiations and legal disputes, while overly broad or invalid claims can lead to challenges and potential invalidation.

Key Takeaways

  • Clear Claims: Patent claims must be clear, concise, and exact to meet statutory requirements.
  • Enablement Requirement: The patent specification must enable a person skilled in the art to make and use the invention.
  • Patent Scope: The scope of a patent is defined by its claims and must be carefully analyzed to understand its breadth and depth.
  • Historical Context: Understanding the historical context and related patents is crucial for a comprehensive analysis.
  • Legal Framework: Compliance with statutory requirements and adherence to court decisions are essential for patent validity.

FAQs

Q: What is the primary purpose of patent claims?

A: The primary purpose of patent claims is to define the scope of protection granted to the inventor.

Q: What is the enablement requirement in patent law?

A: The enablement requirement mandates that the patent specification must describe the invention in such detail that a person skilled in the art can make and use the invention without undue experimentation.

Q: How does the USPTO measure patent quality?

A: The USPTO measures patent quality through various correctness measures and quantifiable compliance targets, including statutory compliance rates for different sections of the Patent Act.

Q: What is the Global Dossier service provided by the USPTO?

A: The Global Dossier service is a set of business services aimed at modernizing the global patent system, providing access to file histories of related applications from participating IP Offices.

Q: Why is the historical context of a patent important?

A: The historical context is important because it helps in understanding the technological and legal environment in which the patent was granted, which can influence its scope and validity.

Sources

  1. GAO Report: Intellectual Property: Patent Office Should Define Quality, Reassess Time Allotted for Examination, and Analyze Incentives.
  2. USAGov: U.S. Patent and Trademark Office (USPTO).
  3. USPTO: Patent Claims Research Dataset.
  4. USPTO: Search for patents.
  5. Supreme Court: Amgen Inc. v. Sanofi.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 4,933,168

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 4,933,168

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 1430176 ⤷  Try for Free
Austria 357702 ⤷  Try for Free
Austria A388376 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 3 of 3 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.